Doç. Dr. MAHMUT BAKIR KOYUNCU
- Yöksis ID 192172
- Researcher ID AAN-7027-2021
- ORCID ID 0000-0002-0507-9294
- Scopus ID
- Scholar ID
- E-posta mahmutkoyuncu@mersin.edu.tr
- Dahili Telefon
Birim
TIP FAKÜLTESİ
DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
İÇ HASTALIKLARI ANABİLİM DALI
DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
İÇ HASTALIKLARI ANABİLİM DALI
ÜAK Temel Alan Bilgisi
Sağlık Bilimleri Temel Alanı
Hematoloji (İç Hastalıkları)
Hematoloji (İç Hastalıkları)
Son 5 Makale
Prognostic Value of Metabolic Tumor Volume and Heterogeneity Index in Diffuse Large B-Cell Lymphoma
MEDICINA-LITHUANIA, vol. 61, no. 8, pp. 1370– Link 2025
Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI
BIOMARKERS IN MEDICINE, vol. 19, no. 17, pp. 1–9 Link 2025
Ten-year journey with myelofibrosis: real-world data and clinical outcomes from a tertiary care center
Journal of Current Hematology & Oncology Research, vol. 3, no. 3, pp. 57–61 Link 2025
Immune and Inflammation Markers as a Predictor of Overall Survival in Patients with Hematologic Malignancies: A Retrospective Cohort Study
MEDICINA-LITHUANIA, vol. 61, no. 6, pp. 1019–10 Link 2025
Don?t neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia
TRANSFUSION CLINIQUE ET BIOLOGIQUE, vol. 30, no. 1, pp. 11–15 Link 2023
MEDICINA-LITHUANIA, vol. 61, no. 8, pp. 1370– Link 2025
Prognostic value of inflammatory-nutritional indexes and HALP score in advanced stage NSCLC treated with first-line TKI
BIOMARKERS IN MEDICINE, vol. 19, no. 17, pp. 1–9 Link 2025
Ten-year journey with myelofibrosis: real-world data and clinical outcomes from a tertiary care center
Journal of Current Hematology & Oncology Research, vol. 3, no. 3, pp. 57–61 Link 2025
Immune and Inflammation Markers as a Predictor of Overall Survival in Patients with Hematologic Malignancies: A Retrospective Cohort Study
MEDICINA-LITHUANIA, vol. 61, no. 6, pp. 1019–10 Link 2025
Don?t neglect the rare adverse event with intravenous immunoglobulin: Hemolytic anemia
TRANSFUSION CLINIQUE ET BIOLOGIQUE, vol. 30, no. 1, pp. 11–15 Link 2023
Son 5 Bildiri
ASXL1 pozitif primer miyelofibrozlu hastalarda tiyol/disülfit dengesi ve klinik önemi
8. Hematolojik Onkoloji Kongresi (18.12.2021 - 19.12.2021) 2021
Orak Hücre Anemili Hastalarda Pnömokok Aşılaması Ağrılı Kriz Nedenli Hastaneye Yatışı Azaltıyor Mu?: Tek Merkez Deneyimi
1. Hematoloji Eğitim ve Araştırma Kongresi (20.11.2020 - 20.11.2020) 2020
Can sarcopenia be a risk factor for bleomycin toxicity?
XIth Eurasian Hematology Oncology Congress (21.10.2020 - 24.10.2020) 2020
Multiple Myelomlu Hastalarımızda Sarkopeninin Genel Sagkalım Üzerine Etkisi
46. Ulusal Hematoloji Kongresi (28.10.2020 - 31.10.2020) 2020
T(4,14) Pozitif Multiple Myelomda Tedavi
Hematoloji Uzmanlık Derneği Ulusal Kongresi 2020 (12.12.2020 - 15.12.2020) 2020
8. Hematolojik Onkoloji Kongresi (18.12.2021 - 19.12.2021) 2021
Orak Hücre Anemili Hastalarda Pnömokok Aşılaması Ağrılı Kriz Nedenli Hastaneye Yatışı Azaltıyor Mu?: Tek Merkez Deneyimi
1. Hematoloji Eğitim ve Araştırma Kongresi (20.11.2020 - 20.11.2020) 2020
Can sarcopenia be a risk factor for bleomycin toxicity?
XIth Eurasian Hematology Oncology Congress (21.10.2020 - 24.10.2020) 2020
Multiple Myelomlu Hastalarımızda Sarkopeninin Genel Sagkalım Üzerine Etkisi
46. Ulusal Hematoloji Kongresi (28.10.2020 - 31.10.2020) 2020
T(4,14) Pozitif Multiple Myelomda Tedavi
Hematoloji Uzmanlık Derneği Ulusal Kongresi 2020 (12.12.2020 - 15.12.2020) 2020